Monitor future Forms 4 for insider transactions, as this filing establishes reporting compliance but discloses no current ownership. The power of attorney suggests administrative streamlining, not a material change in control or intent.
TYRA drugs
TYRA drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 21 $36.69entry
- T+1 · 7mo ago +1.80%α +0.78% · $37.35
- T+5 · 7mo ago −4.44%α −5.53% · $35.06
- T+20 · 6mo ago −2.81%α −7.72% · $35.66
- T+60 · 4mo ago −13.85%α −20.74% · $31.61
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Habib J. Dable, a reporting person at Tyra Biosciences, filed a Form 3 and granted a power of attorney to the company's General Counsel and CFO to file required SEC ownership reports on his behalf. The filing indicates no current beneficial ownership of TYRA shares.
Key Facts
- Habib J. Dable filed Form 3, indicating initial reporting status.
- Filed a power of attorney authorizing Ali Fawaz (General Counsel) and Alan Fuhrman (CFO) to file SEC Forms 3, 4, 5, 13D/G, and Form 144 on his behalf.
- Disclosure states 'No securities are beneficially owned' as of April 16, 2026.
- No transactions or shareholdings were reported.
Financial Impact
No financial impact, no shares reported as beneficially owned.
Risk Factors
- Potential perception of reduced insider ownership transparency due to delegated filing authority, though legally standard.
- Lack of disclosed ownership may signal limited current stake by the reporting person.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-164080 |
| Document: 0001193125-26-164080-index-headers.html | 0001193125-26-164080 |
| Document: 0001193125-26-164080-index.html | 0001193125-26-164080 |
| Document: 0001193125-26-164080.txt | 0001193125-26-164080 |
Track record
13 reports on TYRA
3 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +20.37% at T+60 after the Jun 26, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 10, 20266d ago 8-K Neutral 4/10 Entry $21.00 Now $19.74 −6.00% settles Nov 17
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $21.75 to $21.53 Now $19.74 −9.24% ▼ −1.03% −0.32% vs SPY
- Sep 21, 20268w ago SC 13G Neutral 4/10 Entry $25.57 to $21.98 Now $19.74 −22.80% ▼ −14.04% −12.85% vs SPY
- Sep 17, 20268w ago Insider Cluster Bullish 8/10 Entry $25.73 to $21.76 Now $19.74 −23.28% ▼ −15.43% −16.70% vs SPY
- Sep 14, 20269w ago S-3ASR Neutral 3/10 Entry $25.07 to $25.65 Now $19.74 −21.26% ▲ +2.31% +2.21% vs SPY
- Sep 9, 20269w ago 8-K Bullish 6/10 Entry $22.01 to $24.35 Now $19.74 −10.31% ▲ +10.63% +11.73% vs SPY
- Aug 4, 202614w ago 424B5 Bearish 6/10 Entry $25.71 to $25.30 Now $19.74 +23.22% ▲ +1.59% +1.95% vs SPY
- Jun 26, 202620w ago 144 Bearish 6/10 Entry $32.11 to $30.86 Now $19.74 +38.52% ▲ +3.89% +5.28% vs SPY
- May 13, 202626w ago 8-K Mixed 5/10 Entry $36.19 to $33.78 Now $19.74 −45.45% ▼ −6.66% −5.50% vs SPY
- Apr 20, 202630w ago 3 Neutral 2/10 Viewing Entry $36.69 to $35.06 Now $19.74 −46.20% ▼ −4.44% −5.53% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers